-
The Street Debates Whether Best Buy Investors Should Buy The Dip
Friday, May 22, 2020 - 4:27pm | 1018Read More...Electronics retailer Best Buy Co., Inc. (NYSE: BBY) reported Thursday first quarter results, highlighted by a 5.7% year-over-year drop in comps which was still better than expected. EPS also came in better than expected but the stock traded lower as investors debated its outlook in an uncertain...
-
Apple Vs. Tesla: Morgan Stanley Breaks Down The Parallels
Thursday, May 21, 2020 - 1:25pm | 501Read More...Whether Tesla Inc (NASDAQ: TSLA) should be valued as a car company or tech company is still up for debate in the investment community. But recent trends have sent Morgan Stanley’s Adam Jonas seeking advice from his Apple Inc. (NASDAQ: AAPL) colleagues. Apple's market cap sits...
-
Facebook's New Shopping Feature Lifts Stock To All-Time Highs
Wednesday, May 20, 2020 - 1:10pm | 653Read More...Facebook, Inc. (NASDAQ: FB) launched a new e-commerce featured called "Shops" that could better position the company to compete against more established third-party e-commerce platforms. Facebook said it's working closely with partners like Shopify Inc (NYSE: SHOP) to better give...
-
Moderna Analyst Says Coronavirus Vaccine Candidate Has 65% Chance Of Success
Wednesday, May 20, 2020 - 12:00pm | 439Read More...Morgan Stanley, which recently named Moderna Inc (NASDAQ: MRNA) as one of the likeliest candidates to succeed in the coronavirus vaccine race, reviewed the interim Phase 1 data released by the company Monday. The Moderna Analyst Matthew Harrison maintained an Overweight rating on Moderna...
-
These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley
Monday, May 18, 2020 - 12:07pm | 589Read More...With about eight coronavirus vaccine candidates in clinical trials and 110 more in clinical testing, the race to a commercial product is intensifying. Against this backdrop, an analyst at Morgan Stanley looked at the most promising programs. Millions of doses of the vaccine could be...
-
Microsoft's $5B Security Segment Approaches $55B Market Opportunity
Friday, May 15, 2020 - 9:18am | 332Read More...Microsoft Corporation (NASDAQ: MSFT) suffered as badly as anyone from the coronavirus (COVID-19) pandemic-related market decline, but it’s since recovered just about all of its stock losses, and one analyst team expects the company to post double-digit top-line growth in the near term. The...
-
Morgan Stanley Analyst Says Many Investors 'Absolutely Adore' Musk's Dominating Strategy
Thursday, May 14, 2020 - 6:48am | 433Read More...Morgan Stanley analyst Adam Jonas on Wednesday said Tesla Inc. (NASDAQ: TSLA) Chief Executive Officer Elon Musk's stance against county orders are appreciated by many investors. Tesla CEO's 'Wanton Disregard' For Traditions Seen As Strength Musk's style has been a...
-
AbbVie's Potential Is 'Underappreciated,' Says Morgan Stanley Analyst
Wednesday, May 13, 2020 - 12:03pm | 511Read More...Despite the pandemic risk, one analyst at Morgan Stanley remains bullish on AbbVie Inc (NYSE: ABBV). The AbbVie Analyst David Risinger maintained an Overweight on AbbVie with a $95 price target. The AbbVie Thesis Risks to U.S. sales stemming from unemployment and the Humira patent cliff...
-
Analysts Still All-In On Uber Despite Mixed Q1 Results, Coronavirus Environment
Friday, May 8, 2020 - 10:41am | 1081Read More...Like rival Lyft Inc (NASDAQ: LYFT), Uber Technologies Inc (NYSE: UBER) reported mixed first-quarter earnings with a big bottom-line miss and significant top-line beat. But by and large, analysts offered glass-half-full interpretations. The Details Morgan Stanley celebrated 20% rides bookings growth...
-
5 Analysts Weigh In On Lyft's Mixed Q1
Thursday, May 7, 2020 - 1:36pm | 1073Read More...Lyft Inc (NASDAQ: LYFT)’s stock plunged Wednesday on news of job cuts and opex reductions, but the company seemed to redeem itself with a first-quarter sales beat after the close. Lyft’s $955.71 million in sales exceeded estimates of $897.86 million, even as a bottom-line loss of $...
-
Analysts React To Square Earnings: 'A Tale Of Two Ecosystems'
Thursday, May 7, 2020 - 12:29pm | 495Read More...Square Inc (NYSE: SQ) shares rocketed higher by 11% on Thursday after the company reported losses that more than doubled in the first quarter of 2020. Square reported a first-quarter adjusted earnings per share loss of 24 cents, missing analyst expectations of a 13-cent profit. However, revenue of...
-
Twilio Analysts Hike Price Targets As Cloud Company Reports Beat-And-Raise Quarter During Pandemic
Thursday, May 7, 2020 - 11:16am | 832Read More...Twilio Inc (NYSE: TWLO), a cloud communications platform-as-a-service company, reported stellar first-quarter results Wednesday, sending its shares higher into record territory. The Twilio Analysts Wells Fargo Securities analyst Michael Turrin maintained an Overweight rating on Twilio shares and...
-
Disney's Business Hit Hard By The Coronavirus: Is Now A Buying Opportunity For The Stock?
Wednesday, May 6, 2020 - 11:14am | 720Read More...Walt Disney Co (NYSE: DIS) shares bounced on Wednesday after the company reported mixed fiscal second-quarter earnings on Tuesday afternoon. Disney said parks and cruise operating income plummeted 58% in the quarter, but coronavirus (COVID-19) shelter-in-place measures also significantly boosted...
-
6 Reasons Why Morgan Stanley Says Tesla's Next Gigafactory Location Is Texas
Tuesday, May 5, 2020 - 11:53am | 539Read More...Tesla Inc (NASDAQ: TSLA) shares have recovered from their coronavirus meltdown, courtesy of a strong quarterly report. On the earnings call, CEO Elon Musk suggested the company's next Gigafactory could be announced as soon as next month and that it would be in the U.S. An analyst at...
-
Gilead Analysts See Questionable Commercial Opportunity For Coronavirus Candidate Remdesivir
Friday, May 1, 2020 - 3:00pm | 851Read More...Gilead Sciences, Inc. (NASDAQ: GILD) reported an earnings and sales beat Thursday, but apprehension surrounding the drugmaker's remdesivir, under evaluation as a potential COVID-19 treatment, are weighing down on the stock. The Gilead Analysts Wells Fargo Securities analyst Jim...
